연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1010 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| First Very Long Baseline Interferometry Detections at 870 μm | Zhang, Shuo | Zhang, S | 276 | Michigan State Univ, Dept Phys & Astron, 567 Wilson Rd, E Lansing, MI 48824 USA | HKF-4868-2023 | Zhang, Shuo | 0000-0002-2967-790X | Zhang, Shuo | sdoeleman@cfa.harvard.edu; | |
| First Very Long Baseline Interferometry Detections at 870 μm | Zhao, Guang-Yao | Zhao, GY | 277 | Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany | sdoeleman@cfa.harvard.edu; | |||||
| First Very Long Baseline Interferometry Detections at 870 μm | Zhao, Guang-Yao | Zhao, GY | 277 | Inst Astrofis Andalucia CSIC, Glorieta Astronomia S-N, E-18008 Granada, Spain | sdoeleman@cfa.harvard.edu; | |||||
| First Very Long Baseline Interferometry Detections at 870 μm | Zhao, Shan-Shan | Zhao, SS | 278 | Chinese Acad Sci, Shanghai Astron Observ, 80 Nandan Rd, Shanghai 200030, Peoples R China | sdoeleman@cfa.harvard.edu; | |||||
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Schmid, Peter | Schmid, P | 1 | 교신저자 | Queen Mary Univ London, Barts Canc Inst, London, England | LDG-1690-2024 | SCHMID, PETER J | p.schmid@qmul.ac.uk; | ||
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Schmid, Peter | Schmid, P | 1 | 교신저자 | Barts Canc Inst, Ctr Expt Canc Med, Old Anat Bldg, London EC1M 6BQ, England | LDG-1690-2024 | SCHMID, PETER J | p.schmid@qmul.ac.uk; | ||
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Turner, Nicholas C. | Turner, NC | 2 | Royal Marsden NHS Fdn Trust, London, England | 0000-0001-8937-0873 | Turner, Nicholas | p.schmid@qmul.ac.uk; | |||
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Turner, Nicholas C. | Turner, NC | 2 | Breast Canc Now Res Ctr, London, England | 0000-0001-8937-0873 | Turner, Nicholas | p.schmid@qmul.ac.uk; | |||
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Barrios, Carlos H. | Barrios, CH | 3 | Hosp Sao Lucas, Ctr Pesquisa Oncol, PUCRS, Latin Amer Cooperat Oncol Grp LACOG, Sao Paulo, Brazil | HJG-7197-2022 | Barrios, Carlos | p.schmid@qmul.ac.uk; | |||
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Isakoff, Steven J. | Isakoff, SJ | 4 | Massachusetts Gen Hosp, Boston, MA USA | ABE-3566-2020 | Isakoff, Steven | p.schmid@qmul.ac.uk; | |||
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Kim, Sung-Bae | Kim, SB | 5 | Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea | AAI-3081-2021 | Kim, Sung | 0000-0001-5588-8332 | Kim, Sung-Bae | p.schmid@qmul.ac.uk; | |
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Sablin, Marie-Paule | Sablin, MP | 6 | Inst Curie, Dept Drug Dev & Innovat D3i, Paris, France | p.schmid@qmul.ac.uk; | |||||
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Saji, Shigehira | Saji, S | 7 | Fukushima Med Univ, Dept Med Oncol, Fukushima, Japan | MFH-6808-2025 | Saji, Shigehira | 0000-0002-6732-8030 | Saji, Shigehira | p.schmid@qmul.ac.uk; | |
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Savas, Peter | Savas, P | 8 | Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Australia | 0000-0001-5999-428X | Savas, Peter | p.schmid@qmul.ac.uk; | |||
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Savas, Peter | Savas, P | 8 | Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Australia | 0000-0001-5999-428X | Savas, Peter | p.schmid@qmul.ac.uk; |
페이지 이동: